Cephalon, Inc., (Nasdaq: CEPH) Receives FDA Approval for TREANDA

Tags:
Cephalon FDA Approval Treanda Indolent Non-hodgkin's Lymphoma NHL Cancer Treatments B-cell Patients
MultiVu
  • Submitter:
    MultiVu
  • Visits: 71,685
  • Subscribers: 60
  • Comments: 0
  • Updated: 13-Jul-09
  • Videos: 1654
  • International International
  • Comments: 0
  • Views: 106
  • Added: 03-Nov-08

Cephalon, Inc., (Nasdaq: CEPH) today announced that the U.S. Food and Drug Administration (FDA) approved TREANDA

  1. Categories: News & Events
Comments on

Cephalon, Inc., (Nasdaq: CEPH) Receives FDA Approval for TREANDA

0 Comments | Be the first to comment
 
kpins